Speakers and Conference Guests

Speakers

Christine Dufès, PhD.

University of Stathclyde, UK

C Dufes photo.jpg

Dr Christine Dufès is a Reader (Associate Professor) in Nanomedicine and Director of the Postgraduate School at the Strathclyde Institute of Pharmacy and Biomedical Sciences (SIPBS). She teaches on the Master of Pharmacy and on various MSc postgraduate degrees. Christine obtained a Doctorate in Pharmacy (with Distinction and congratulations of the Jury, 1997) and a PhD (with a European Label, Distinction and congratulations of the Jury, 2002) from the University of Poitiers (France). After four years as a post-doctoral researcher at the Cancer Research UK Beatson Laboratories in Glasgow, she was appointed as a Lecturer in SIPBS in 2006. Her research focuses on the development of targeted drug- and gene-based nanomedicines for cancer therapy and brain delivery. It resulted in 2 patents, 54 publications, 4 book chapters and attracted 4100+ citations (h-index: 32) (Google Scholar). Christine has been awarded the Bourse d'Excellence Lavoisier (2002), the Award of the 9th Annual Symposium of the United Kingdom and Ireland Controlled Release Society (2003), the Biochemical Journal Young Investigator Award (2009), the Tom Gibson Memorial Award (2012), the Scientist Medal of the International Association of Advanced Materials (2021) and the Outstanding Woman Researcher in Nanomedicine award at the 7th Venus International Women Awards (2021) for her research. She also received the "Best Overall" Strathclyde Teaching Excellence Award (2013) for her teaching, was nominated 10 times since 2013 and was shortlisted in the category "Best in Faculty of Science" in 2015, 2018 and 2022. She is a Fellow of the Higher Education Academy, a Trustee of the British Society of Nanomedicine, Strathclyde Network Lead for the UK Reproducibility Network, Senior Editor of Journal of Interdisciplinary Nanomedicine, Editorial Advisory Board member of Biomaterials Science, Review Editor in Frontiers in Bioengineering and Biotechnology – Nanobiotechnology, and Member of the Editorial Boards of 6 journals (Journal of Liposome Research, Journal of Nanotechnology: Nanomedicine & Nanobiotechnology, Journal of Pharmaceutical Sciences, Pharmaceutical Nanotechnology, Pharmaceutics and Scientia Pharmaceutica).

Barbara R Conway, PhD.

University of Huddersfield, UK

Professor Barbara Conway is the Head of Pharmacy at the University of Huddersfield, Director of the Pharmaceutics and Formulation Research Centre and co-director of a multi-disciplinary research institute, the Institute of Skin Integrity and Infection Prevention (ISIaIP) and the International Clinical Practice Research Unit (ICPRU), a collaboration between university of Huddersfield and JUST. She graduated in Pharmacy from Queens University Belfast and received her PhD in pharmaceutical formulation from Aston University. She has a multidisciplinary research portfolio with expertise across formulation development, pharmaceutical analysis, and drug delivery strategies with a strong focus on translation into clinical practice. She was also a Medici Fellow, specializing in driving forward innovation within the university sector and hold several patents in the pharmaceutical area. She has supervised over 50 Ph.D. students and on-going research programmes focus on strategies to improve skin antisepsis and delivery of antimicrobials, antimicrobial stewardship, solubility enhancement for poorly soluble drugs, and development and characterisation of novel formulations. She has published more than 150 peer-reviewed articles, along with patents, book chapters and conference abstracts.

Mamoon Aldeyab, PhD.

University of Huddersfield, UK

Dr Aldeyab is a registered pharmacist in the UK (PSNI), Senior Lecturer in Clinical Pharmacy in the Department of Pharmacy at the University of Huddersfield (England), and Honorary Senior Research Epidemiologist at the Public Health Agency (Northern Ireland). He earned his MSc in clinical pharmacy from Strathclyde University, MSc in epidemiology and PG certificate in pharmacoepidemiology and pharmacovigilance from London School of Hygiene and Tropical Medicine at the University of London, and PhD in clinical pharmacy from Queen's University Belfast. His research interest includes clinical pharmacy with a particular focus on antibiotic surveillance, antibiotic stewardship, interventions to control healthcare-acquired infections, and antibiotic benchmarking. He has more than 80 publications. Dr Aldeyab was awarded the UK Clinical Pharmacy Association Antimicrobial Management Award in recognition of his work helping hospitals to establish priorities for controlling the use of specific antibiotics and minimising the spread of healthcare-acquired infections.

Craig Anderson

Director, R&D Lead, Pfizer

As Director, R&D Lead at Pfizer, Craig Anderson is responsible for research, development, and business related functions across the International Labeling organization. In addition to having biopharmaceutical industry experience, Craig also has prior experience from Health Canada where he led various informatics projects ranging from the implementation of data standards to Structured Product Labelling. Craig is also co-lead of HL7’s Vulcan accelerator project for electronic Product Information (ePI) and co-lead for HL7 BR&R's Pharmaceutical Quality (Industry Use Case) project.

Nadine Jagerovic

Spanish National Research Council, Spain

Dr. Jagerovic defended her Ph.D. thesis at the University of Burgundy in France in 1990. Then she moved to the University of California Davis, in US, as a postdoctoral fellow. Two years later she joined the Spanish National Research Council at the Medicinal Chemistry Institute in Madrid, Spain, with a Marie Curie Fellowship, where she was later appointed with a permanent position. Dr. Jagerovic was technical vice-director of her Institute from 2015 to 2019.

Over the last 15 years, her scientific interests are focused on the discovery of modulators of G protein-coupled receptors related to the endocannabinoid system. Her ongoing research support comes from grants from the Spanish Ministry, from the US National Institute of Health, and a biotechnological company. She has a solid track record in publishing in high impact peer-reviewed journals (126 scientific articles). Her know-how in technology transfer allowed her to patent the results of her lab and licensed some of them to biotech and pharmaceutical companies (14 international patents). She is the director of 5 PhD theses and she currently co-supervises 3 PhD candidates. She usually receives national and foreign personnel in training. She very much believes in multi-disciplinary and across institutional collaborative research.

Ivo Abraham, PhD.

University of Arizona, USA

Dr. Ivo Abraham is a Professor in the Department of Pharmacy Practice at the University of Arizona. Dr Abraham has (co-)authored more than 260 articles and more than 60 chapters, and has (co-)edited 29 books, monographs, and journal issues. Dr. Abraham's research primarily focuses on clinical outcomes and effectiveness, specifically examining the association between variability in treatment regimens and patient outcomes. His research group explores various factors such as treatment timing, influencing factors, patient-clinician compatibility, treatment tolerability, and the impact of patient, clinician, and treatment center on outcomes, utilizing a comprehensive framework and statistical models from diverse disciplines in biomedical research.

Noor Obeidat, PhD.

King Hussein Cancer Center, Jordan

Dr. Nour Obeidat is the director of the Cancer Control Office at King Hussein Cancer Center and the director of KHCC’s Tobacco Dependence Treatment CTTTP-accredited Training Program. Dr. Obeidat holds a PhD in Health Outcomes Research and has focused the majority of her research on Cancer and Tobacco Control. Her applied research work spans various cancer control related topics, including characterizing and evaluating tobacco dependence treatment services, estimating the survival benefits of smoking cessation in cancer patients, understanding physician-reported barriers to offering tobacco dependence treatment, evaluating the impact of waterpipe use on young adults’ health, evaluating community perspectives regarding tobacco control and pictorial warning labels.

Enas I. Hasan, MSc.

Pharmaceutical Research Unit, Jordan

Enas Hasan is the General Manager of PRU (Pharmaceutical Research Unit); a Jordanian CRO with Jordan, US FDA, EU, GCC, Turkish and Malaysian accreditations. She spent 22 years in various roles in the Pharmaceutical Industry, in R&D, Technical, Licensing, Intellectual properties and Regulatory Affairs Departments; in JPM and HIKMA Pharmaceuticals; before joining PRU in April 2020. She earned a M.Sc. in Pharmaceutical Sciences from the University of Jordan in 2000, and Bachelor degree in Pharmacy from the same university in 1997. In September of 2019, she decided to follow her dream and enroll in the Ph.D. program of Pharmaceutical Technology in the Jordan University of Science and technology.

Muhammed Alzweiri, PhD.

University of Jordan, Jordan

Dr. Muhammed Alzweiri is a professor in pharmaceutical analysis at the University of Jordan. He graduated from the University of Jordan in 1998, then he did his master degree from the same University in 2003. After that, he finished his PhD from the University of Strathclyde in 2009. He has published more than 50 scientific papers so far.

Nimer Alkhatib, PhD.

University of Arizona (USA); and Al-Zaytoonah University of Jordan (Jordan)

Nimer has over 12 years of work experience in various health care sectors worldwide. In 2011, Nimer completed his PharmD degree from the Jordan University of Science and Technology in Jordan. During his studies, he served in World Health Organization (W.H.O) and as a regional projects officer for the International Pharmaceutical Students' Federation (IPSF). Right after his graduation, he worked in community pharmacies and pharmaceutical industry in the middle east region. Then, between 2015 to present, Nimer has served as a health economic analyst and consultant for various health care agencies and pharmaceutical industry in the USA and Europe. During the period of 2015 to 2019, Nimer received a full scholarship for graduate studies from the Center of Health Outcomes and PharmacoEconomic Research (HOPE center)/University of Arizona, USA. In 2019, Nimer received his PhD in Pharmaceutical Sciences in the major of pharmaceutical economics and outcome research from the University of Arizona, USA. In 2017, Nimer received his Master degree in Pharmaceutical Sciences in the major of pharmaceutical economics and outcome research from the University of Arizona, USA. Nimer has received many excellence awards for his academic performance throughout his academic career. During Nimer's journey with graduate school, he had the honor to lead projects for the Department of Health Services (Arizona), Banner University Hospital, Matrix_45 Health Care. LLC, and Precision Medicine Initiative. Nimer has presented the HOPE center in many conferences, working meetings, and interviews in the US. Based on these experiences and more, Nimer has a great scientific contribution to make to the health care community. His publications have topped the number of 52 over the last 5 years, being published in high-tiered journals like Journal of American Medical Association (JAMA), Blood, Journal of Medical Economics (JME) and others. Nimer focus is in the value of health care and methods for value-based pricing. Currently Nimer serve as business partner and advisory board member with Pi Pharma Intelligence. In this position Nimer helps Pi Pharma Intelligence to integrate with academia and optimize the usability of Pi data in scientific research.

Qasem AlRadaideh, PhD.

Yarmouk University, Jordan

Dr. Qasem AlRadaideh is a Professor of Data Science and Artificial Intelligence at Yarmouk University. Currently he is the dean of the faculty of Information Technology and Computer Sciences. Prof. AlRadaideh received his Ph.D. in the Data Mining field from the University Putra Malaysia (UPM) in 2005. His research interest includes Applications of Artificial Intelligence in different domains including Medical Domain, Natural Language Processing and Arabic Language Computation. He has several publications in the areas of Artificial Intelligence applications such as text Mining and Arabic Language Computation. In 2012, Prof. AlRadaideh received the Hisham Hijjawi Prize in the ICT track.

Fadia Mayyas, PhD.

Jordan University of Science and Technology, Jordan

Image (3) (1).jpeg

Dr. Fadia Mayyas is a professor in Clinical Pharmacy at Jordan University of Science and Technology (JUST). She completed a Ph.D in translational molecular medicine/molecular cardiology at Case Western Reserve University and Cleveland Clinic, USA. Dr. Mayyas is an awardee of the American Heart Association doctoral fellowship and the doctoral excellence award in molecular medicine/Cardiology, USA 2011. She joined the faculty of pharmacy at JUST as an assistant professor in 2011 and promoted to a full professor in 2020. Dr. Mayyas has more than 50 publications in human and animal models of cardiovascular diseases including coronary artery disease, heart failure and arrhythmia.

Fouad Darras, PhD.

CEO - Bara’a for Pharmaceutical Patent Consultation, Jordan

Dr. Fouad Darras has extensive experience, combined with his academic achievements, including a Ph.D. in medicinal chemistry from Regensburg UniversityGermany and a Master's degree in intellectual property rights (LL.M) from the University of Turin-Italy, has positioned him as a prominent figure in the healthcare and pharmaceutical sectors. In addition, his entrepreneurial spirit, research acumen, and dedication to intellectual property rights have made him a respected leader and a valuable asset to the industry. Dr. Fouad Darras is a highly accomplished professional with a diverse background in the healthcare and pharmaceutical industries. With extensive experience in various healthcare institutes and companies, he has significantly contributed to intellectual property, research, and entrepreneurship. From 2018 to 2022, Dr. Darras served as the Intellectual Property Head at MS Pharma in Amman, Jordan. In this role, he was pivotal in managing and protecting the company from infringing any patent holder rights, ensuring compliance with legal regulations. From 2016- 2018, Dr. Darras has served as a Principal Investigator at the prestigious Mayo Clinic in Minnesota, USA. In this capacity, he leads and oversees groundbreaking research projects, contributing to advancements in medical science and patient care. In 2018, Dr. Darras is the Founder and Executive Chairman of the Resonance Research Lab in Amman, Jordan. Where this lab in supporting the pharmaceutical industry in all needed impurities synthesized by Jordanian chemists. In 2022, Dr. Darras embarked on a new venture by establishing his own business, Baraa for Pharmaceutical Patent Consultation, based in Amman, Jordan. As the founder and CEO, he focused on providing specialized consulting services related to pharmaceutical patents. His expertise in intellectual property and pharmaceutical sciences allowed him to assist Bara's clients in navigating the complex landscape of patents in all their portfolios, allowing them to direct their investment in the right direction and reducing the risk of litigation.

Ali Hmedat, PhD.

Yarmouk University, Jordan

photoo Ali (1).JPG

Dr. Ali Hmedat is an Assistant Professor of Pharmaceutical Biotechnology at Yarmouk University. He received his BSc in Pharmacy from Jordan University of Science and Technology. Then he completed his Master's and Ph.D. in Pharmaceutical Biotechnology from Martin Luther University, Germany. His research centers around tumor biology, molecular oncology, combination treatments for head and neck cancer, IGF2BP1's role in ovarian and head and neck cancer and assessing compound efficacy and safety for anticancer activity.

Khaldun Al Azzam, PhD.

Al-Ahliyya Amman University, Jordan

Dr. Khaldun Mohammad Al Azzam is an Associate Professor of Analytical Chemistry, Pharmaceutical Sciences Department, Faculty of Pharmacy, Al-Ahliyya Amman University. Dr. Al Azzam obtained his PhD in analytical chemistry in 2011 from the School of Chemical Sciences, Universiti Sains Malaysia (USM), Malaysia. He published more than 70 papers in peer-reviewed journals. He serves on the editorial boards/reviewer for over 25 journals.

Shah Alam Khan, PhD.

National University of Science and Technology, Oman

Dr. Shah Alam Khan is currently working as a Professor of Pharmaceutical Medicinal Chemistry at the College of Pharmacy, National University of Science and Technology, Muscat, Oman (In academic partnership with West Virginia University, USA). He received his Ph.D. from Jamia Hamdard University, New Delhi, India in 2003 for studying the chemistry and role of Silybum marianum (Milk thistle), silymarin and its synthetic analogues in the hepato-protection. He is a recipient of Junior Research Fellowship (JRF-UGC, GATE qualified) and Senior Research fellowship (SRF, CSIR) from the Government of India for pursuing master's and doctorate degrees. He has more than 20 years of teaching and research experience. He has been serving NU (formerly known as Oman Medical College) for the past twelve years. His field of research interests includes synthesis and biological evaluation of natural products and synthetic heterocyclic compounds. He has contributed in more than 175 full length research articles in the national/international journals of repute. He is an editorial board member of several international journals and has reviewed scientific papers in the field of pharmaceutical sciences for more than 50 journals. He has supervised 38 undergraduate and post graduate research projects. Several of these projects have received awards in poster/oral presentation category at international conferences. He has successfully completed five funded research projects. He has been invited as a guest speaker in several national and international conferences. He was awarded 'Best Teacher' in Pharmacy at Oman Medical College for the academic year 2010-11, and 2011-12 and 2015-16. He is a life member of many professional bodies such as IPA, ATINER, IPGA and APTI.

Youssef Naimi, PhD.

Hassan II University of Casablanca, Morocco

Prof. Youssef Naimi is a material scientist, graduated from "Pierre & Marie Curie University", Paris, France with a DEA (Master) and Doctoral thesis in 1994 in Chemistry (optimization of the hydrogen electrode in H2/O2 solid polymer Fuel Cell. He works as Associate Professor at Ben M'Sick Faculty of Science, Hassan II University of Casablanca. He conducted research for on the optimization of electrodes of Protons Exchange Membrane Fuel Cells, and obtained his state Doctorate in 2006. Dr. Youssef Naimi was conducting research, managing research students, recruiting top talents. He was a member of the network of Microelectrodes users since 2003. He was Co-responsible for the fuel cell program of the inter-university scientific cooperation project of the Francophonie Universities Agency (AUF) (2005-2007). He is Co-responsible of the LEAP-RE project "A data driven digital twin for improved hydrogen storage vessels towards challenges for energy transition" which regroups laboratories from France, Romania, South Africa and Morocco. He is now Director of the Physical Chemistry of Materials Laboratory, Head of the Chemistry Department, Coordinator of the Renewable Energies and Materials Master at Faculty of Sciences Ben M'Sick, Hassan II University of Casablanca, Morocco.

Esra’a Alomari, PhD.

Isra University, Jordan

Dr. Esra’a Alomari is an assistant professor of Pharmaceutical Biotechnology and Clinical Pharmacology at Isra University in Amman, Jordan. She obtained a doctor of pharmacy degree (Pharm-D) from Jordan University of Science and Technology in 2012. Alomari received her Ph.D. in Biotechnology and Pharmacology from the University of Parma, Italy, in 2020. After completing her Ph.D., Dr. Alomari pursued postdoctoral training in the field of Biomedicine at Parma University. Her research interests primarily revolve around protein therapeutics for clinical applications. She has expertise in various aspects of this field, including rDNA technology, recombinant protein expression, in vivo experiments, and pharmacological studies to evaluate the efficacy and safety of proteins. As a testament to her contributions to the field, Dr. Alomari's research findings have been published in reputable scientific journals.

Hayaa Banat, BSc.

Jordan Food and Drug Administration, Jordan

Hayaa Banat is a Senior pharmacovigilance specialist and the Head of Pharmacovigilance Section in Jordan Food and Drug Administration (JFDA). Hayaa Banat received her Pharm.D. Degree from Jordan University of Science and Technology and is currently working at Jordan food and Drug Administration (JFDA) as the head of pharmacovigilance section. A strong advocate of increasing awareness of the importance of rational drug use, Pharmacovigilance and drug safety. Hayaa participated in several national and international meetings and conferences regarding Pharmacovigilance, quality use of medicines, effective communication. She has an active role in risk management plan (RMP) evaluation, risk minimization measures (RMM) implementation, patient leaflet updates. Hayaa is anxious in encouraging health care providers to build a culture based on patient safety. She has active role in implementing the antimicrobial resistance National Action Plan. Hayaa has published many articles in the area of pharmacovigilance and antimicrobial resistance. Has a good experience in clinical practice mainly in critical care units (ICU, CCU) as she worked as a clinical pharmacist at hospitals in Jordan, King Hussein Cancer Center and Jordan university Hospital.

Tarun Wadhwa, PhD.

RAK Medical & Health Sciences University, UAE

Dr. Tarun Wadhwa is presently working as ‘Associate Professor’ in the Department of Clinical Pharmacy & Pharmacology, RAK College of Pharmacy, RAK Medical & Health Sciences University, Ras Al Khaimah, UAE. He completed his doctorate in ‘Clinical Pharmacy’ from KLE University, Belgaum, Karnataka, India. He did Masters of Pharmacy in ‘Pharmacy Practice’ from Manipal College of Pharmaceutical Sciences, Manipal, Karnataka, India in 2007 and graduated in Bachelor of Pharmacy from M.D. University, Rohtak, Haryana, India in 2004. He has also received senior research fellowship from Indian Council of Medical Research (ICMR) in Pharmacovigilance (drug safety). His areas of interest are Pharmacovigilance, Medication safety, Pharmacoeconomics, Clinical Research, Rational Use of Medicines, Medication Concordance and Medication Reconciliation. He is having a rich experience in the field of medication safety. He has presented many scientific papers in National and International conferences. He has also been invited as ‘Resource Speaker’ in various conferences, workshops, CPD and symposium. He is being recognized for his contribution through scientific publications in National and International Peer Reviewed Journals. He is a member of many professional bodies like Indian Pharmaceutical Association, Society of Pharmacovigilance, India, Indian Pharmacological Society etc. Being a part of this profession, he has been involved in clinical pharmacy activities and community engagement services. Presently, in academics, he teaches pharmacy practice and pharmacovigilance courses to B. Pharm and Principles of Clinical Pharmacy Practice, Pharmacotherapeutics-2 & 3 and Hospital Pharmacy & Pharmacoinformatics to MS Clinical Pharmacy Students. He has been actively involved in providing full-fledged training to undergraduates and graduates in developing clinical pharmacy skills in areas like patient counseling, case analysis, preparing pharmaceutical care plan, SOAP format, demonstrating counseling aids, monitoring ADRs, ADR analysis, health screening etc., facilitating student research and scholarly activities, role plays, health days celebration and clinical rotations.

Qosay Al-Balas, PhD.

Jordan University of Science and Technology, Jordan

Prof. Qosay Al-Balas finished his Bachelor degree in pharmacy in the year 2000 from Jordan University of Science & Technology (JUST) and master degree in 2004 in phytochemistry from the same institution. In 2008 he finished his PhD in pharmaceutical sciences from Strathclyde University, UK. Since then, he was appointed at JUST and in 2019 he was granted a full professorship. At 2014 he was appointed as chairman of "Pharmaceutical Research Center" at King Abdulla University Hospital (KAUH) in Jordan. He also occupied many managerial positions at JUST.

His research interest is forked to two main disciplines; medicinal Chemistry & Drug Design in addition to Islamic Bioethics. He has more than 60 publications and the main research area is zinc metallo-enzymes inhibition (Glyoxalase-I as anticancer target).

Dr. Mohanad Odeh, PhD.

Hashemite University, Jordan

Dr. Mohanad Odeh is an Associate Professor in Clinical Pharmacy at Hashemite University. Dr. Odeh is a highly experienced and accomplished individual with expertise in Clinical Pharmacy, Pharmacy Management and Development, Strategic Consulting, Pharmacy Education, Pharmaceutical Care Innovation, and Drug Policy.

Mohammad Alsaggar, PhD.

Jordan University of Science and Technology, Jordan

Mohammad Alsaggar is an Associate Professor of Pharmaceutical Biotechnology. Alsaggar received his BS in pharmacy in 2009 from the Jordan University of Science and Technology (Irbid, Jordan), and PhD in Pharmaceutical and Biomedical Sciences from University of Georgia (Georgia, USA) in 2016. His research focusses on Biologicals as candidates for drug discovery and development. Current research is centered around the design and development of novel peptides and siRNAs as potential therapies for cancer, infectious and inflammatory diseases management.

Mo'tasem M. Alsmadi, PhD

Jordan University of Science and Technology, Jordan

Dr. Motasem Alsmadi, an associate professor of biopharmaceutics and pharmacokinetics at the Pharmaceutical Technology department in the faculty of pharmacy at JUST pursued. He got his BSc in pharmacy -ranking the first in his batch- from JUST in 2009, after which he was sponsored by JUST to pursue his graduate studies in the pharmaceutical technology program at The University of Iowa from which he got his Ph.D. degree on December 2014. On January 2023, Dr. Alsmadi was appointed as a Joint Faculty at the Nanotechnology Institute at JUST.

Dr. Alsmadi had pursued research related to preclinical pharmacokinetics of novel anticancer drugs and pharmacokinetic analysis of anticancer drugs in the presence of modified body physiology induced by cancer and its induced comorbidities (e.g. renal and hepatic impairment) using physiologically-based pharmacokinetic (PBPK) modeling. Moreover, therapeutic drug monitoring of drugs in saliva to optimize dosing regimens as guided by PBPK modeling was among the research interests of Dr. Alsmadi for immunosuppressants, antibiotics, and central nervous system drugs. This is in addition to Dr. Alsmadi's involvement in the evaluation of the bioavailability of drugs administered by novel formulations intended for oral and sublingual administration. Dr. Alsmadi has expertise related to in vitro, in vivo, and in silico tools used for biopharmaceutics and pharmacokinetics analysis.

Aref Zayed, PhD.

Jordan University of Science and Technology, Jordan

Aref Zayed is an Associate Professor of Pharmaceutical Analysis at the Department of Medicinal Chemistry and Pharmacognosy, Faculty of Pharmacy, Jordan University of Science and Technology (JUST). Research interests include development of novel chromatographic and mass spectrometric methods for pharmaceutical and biomedical applications. His recent research focuses on studying drug-drug interactions using various in vitro and in vivo models.

Dr Zayed obtained his BSc in Pharmacy from JUST and got his Master's and Ph.D. in Pharmaceutical Analysis from Loughborough University in the UK. He was awarded the Overseas Research Scholarship for academic excellence, and the Da Vinci Prize for clinical innovation for his PhD work on platinum cancer drugs. Dr Zayed worked in R&D in Pfizer and GSK in the UK and collaborated with several regional pharmaceutical companies and research centres.

Dr. Nusaiba Al-Nemrawi, PhD.

Jordan University of Science and Technology, Jordan

Dr. Nusaiba Al-Nemrawi is an Associate Professor in Pharmaceutical Technology at Jordan University of Science and Technology. Her current research deals with preparing nanoparticles to be used in the treatment and diagnosis of many diseases including cancer, cystic fibrosis, rheumatoid arthritis and many others. Polymeric and metallic nanoparticles have been prepared in her lab and delivered pulmonary, orally, transdermally and parenterally. Additionally, she also explores the green synthesis of nanoparticles.